These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 36569877)

  • 1. Protective role of engineered extracellular vesicles loaded quercetin nanoparticles as anti-viral therapy against SARS-CoV-2 infection: A prospective review.
    Raghav A; Giri R; Agarwal S; Kala S; Jeong GB
    Front Immunol; 2022; 13():1040027. PubMed ID: 36569877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic applications of extracellular vesicles in the immunopathogenesis of COVID-19.
    Motallebnezhad M; Omraninava M; Esmaeili Gouvarchin Ghaleh H; Jonaidi-Jafari N; Hazrati A; Malekpour K; Bagheri Y; Izadi M; Ahmadi M
    Pathol Res Pract; 2023 Jan; 241():154280. PubMed ID: 36580795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2.
    Chen X; Li H; Song H; Wang J; Zhang X; Han P; Wang X
    J Extracell Vesicles; 2022 Dec; 11(12):e12288. PubMed ID: 36450704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection.
    Fu Y; Xiong S
    J Control Release; 2021 Jul; 335():584-595. PubMed ID: 34089793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention.
    Machhi J; Shahjin F; Das S; Patel M; Abdelmoaty MM; Cohen JD; Singh PA; Baldi A; Bajwa N; Kumar R; Vora LK; Patel TA; Oleynikov MD; Soni D; Yeapuri P; Mukadam I; Chakraborty R; Saksena CG; Herskovitz J; Hasan M; Oupicky D; Das S; Donnelly RF; Hettie KS; Chang L; Gendelman HE; Kevadiya BD
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):270-288. PubMed ID: 33544324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
    Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?
    Xia X; Yuan P; Liu Y; Wang Y; Cao W; Zheng JC
    Immunology; 2021 Aug; 163(4):416-430. PubMed ID: 33742451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles Loaded with Long Antisense RNAs Repress Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Idris A; Shrivastava S; Supramaniam A; Ray RM; Shevchenko G; Acharya D; McMillan NAJ; Morris KV
    Nucleic Acid Ther; 2024; 34(3):101-108. PubMed ID: 38530082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
    Sun R; Cai Y; Zhou Y; Bai G; Zhu A; Kong P; Sun J; Li Y; Liu Y; Liao W; Liu J; Cui N; Xiang J; Li B; Zhao J; Wu D; Ran P
    Front Immunol; 2023; 14():1052141. PubMed ID: 37251406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles in COVID-19 prognosis, treatment, and vaccination: an update.
    Hernández-Díazcouder A; Díaz-Godínez C; Carrero JC
    Appl Microbiol Biotechnol; 2023 Apr; 107(7-8):2131-2141. PubMed ID: 36917275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Extracellular Vesicles: An Intriguing Interplay.
    Pocsfalvi G; Mammadova R; Ramos Juarez AP; Bokka R; Trepiccione F; Capasso G
    Kidney Blood Press Res; 2020; 45(5):661-670. PubMed ID: 32957112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acellular Human Amniotic Fluid-Derived Extracellular Vesicles as Novel Anti-Inflammatory Therapeutics against SARS-CoV-2 Infection.
    Chanda D; Del Rivero T; Ghimire R; More S; Mitrani MI; Bellio MA; Channappanavar R
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19.
    Yasamineh S; Kalajahi HG; Yasamineh P; Yazdani Y; Gholizadeh O; Tabatabaie R; Afkhami H; Davodabadi F; Farkhad AK; Pahlevan D; Firouzi-Amandi A; Nejati-Koshki K; Dadashpour M
    J Nanobiotechnology; 2022 Oct; 20(1):440. PubMed ID: 36209089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exploration of phytocompounds theoretically combats SARS-CoV-2 pandemic against virus entry, viral replication and immune evasion.
    Chen TH; Tsai MJ; Chang CS; Xu L; Fu YS; Weng CF
    J Infect Public Health; 2023 Jan; 16(1):42-54. PubMed ID: 36470006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of extracellular vesicles in COVID-19 virus infection.
    Hassanpour M; Rezaie J; Nouri M; Panahi Y
    Infect Genet Evol; 2020 Nov; 85():104422. PubMed ID: 32544615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong SARS-CoV-2 N-Specific CD8
    Ferrantelli F; Chiozzini C; Manfredi F; Leone P; Spada M; Di Virgilio A; Giovannelli A; Sanchez M; Cara A; Michelini Z; Federico M
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plant Cell-Engineered Gold Nanoparticles Conjugated to Quercetin Inhibit SARS-CoV-2 and HSV-1 Entry.
    Elste J; Kumari S; Sharma N; Razo EP; Azhar E; Gao F; Nunez MC; Anwar W; Mitchell JC; Tiwari V; Sahi S
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.